Bringing together 11 influenza experts from the US CDC, the Chinese CDC, the IHME, senior epidemiologists and virologists from all over the world, the Scientific Committee has been set up to provide recommendations for technical, scientific and related ethical aspects of the GIHSN program.

The Scientific Committee has stressed the importance of collecting high quality timely data to allow for decision making on influenza surveillance and related vaccination programs.

May 25th, 2018

The GIHSN platform is opened to hospitals coordinated by public health institutions willing to share influenza surveillance data and epidemiology expertise with other countries. Selected institutions will receive partial funding from the Foundation for Influenza Epidemiology.

You are a not-for profit institution and you are willing to implement the GIHSN protocol and join the program ?

To inform policy decisions, national health authorities need to understand the burden of influenza disease and the impact of current vaccination programs in their countries.

The GIHSN is a platform able to generate strong epidemiological and medical evidence on the burden of severe influenza and the public health impact of influenza vaccines in partnership with several health authorities.